[Concept and therapeutic management of precocious puberty].
Cassorla
F G
FG
National Institute of Child Health and Human Development, Bethesda, Maryland.
D000293:Adolescent; D001827:Body Height; D001846:Bone Development / Q000187:drug effects; D002648:Child; D005260:Female; D006128:Growth; D006131:Growth Inhibitors / Q000008:administration & dosage; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D007986:Luteinizing Hormone / Q000096:biosynthesis / Q000502:physiology; D011629:Puberty, Precocious / Q000378:metabolism*; D013738:Testolactone / Q000627:therapeutic use
D006131:Growth Inhibitors; D013738:Testolactone; D007986:Luteinizing Hormone; D007654:Ketoconazole
Concepto y manejo terapéutico de la pubertad adelantada.